What are the typical lab values in Mirizzi syndrome, including bilirubin levels and liver enzymes such as Alkaline Phosphatase (ALP), Gamma-Glutamyl Transferase (GGT), Aspartate Aminotransferase (AST), and Alanine Aminotransferase (ALT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Values in Mirizzi Syndrome

In Mirizzi syndrome, laboratory values typically show a cholestatic pattern with markedly elevated alkaline phosphatase (ALP), moderately elevated bilirubin, and variable transaminase elevations. This pattern reflects the extrinsic compression of the common hepatic duct by gallstones impacted in the cystic duct or gallbladder neck.

Typical Laboratory Findings

Cholestatic Markers

  • Alkaline Phosphatase (ALP): Significantly elevated, often >3-4x upper limit of normal (ULN), and can reach levels >1000 U/L 1
  • Gamma-Glutamyl Transferase (GGT): Markedly elevated, typically >300 U/L 1
  • Total Bilirubin: Elevated (typically 2-6 mg/dL), with direct (conjugated) bilirubin predominance reflecting obstructive jaundice 1, 2

Hepatocellular Markers

  • Aspartate Aminotransferase (AST): Moderately elevated, typically 100-300 U/L 1
  • Alanine Aminotransferase (ALT): Moderately elevated, typically 100-300 U/L 1
  • AST/ALT ratio: Often AST ≥ ALT, though this is variable 1

Laboratory Pattern Analysis

The laboratory pattern in Mirizzi syndrome reflects the pathophysiology of extrahepatic biliary obstruction:

  • The predominant cholestatic pattern (elevated ALP and GGT) is due to mechanical obstruction of bile flow from extrinsic compression of the common hepatic duct 3
  • Transaminase elevations are typically less pronounced than cholestatic markers but still significant due to the inflammatory response and partial obstruction 3
  • The degree of hyperbilirubinemia correlates with the severity and duration of biliary obstruction 3

Case Example

In a documented case of Mirizzi syndrome, laboratory values showed 1:

  • AST: 263 U/L
  • ALT: 233 U/L
  • ALP: 1246 U/L (markedly elevated)
  • GGT: 342 U/L
  • Total bilirubin: 5.8 mg/dL
  • Direct bilirubin: 4.6 mg/dL

Diagnostic Considerations

  • The cholestatic pattern in Mirizzi syndrome can be similar to other causes of biliary obstruction, requiring correlation with imaging findings 3, 4
  • Laboratory values alone are insufficient for diagnosis, and further diagnostic tests including ultrasound, MRCP, or ERCP are necessary 3, 4
  • Persistent elevation of cholestatic enzymes (ALP, GGT) with jaundice in a patient with gallstones should raise suspicion for Mirizzi syndrome 2, 4

Clinical Correlation

  • The severity of laboratory abnormalities may correlate with the type of Mirizzi syndrome (simple compression vs. cholecystobiliary fistula) 2, 4
  • Laboratory values may fluctuate depending on the degree of obstruction, which can be intermittent in some cases 4
  • Recurrent cholangitis may be present, with associated leukocytosis and elevated inflammatory markers 3, 2

Laboratory values in Mirizzi syndrome, while not diagnostic on their own, provide important clues to the presence of biliary obstruction and should prompt appropriate imaging studies for definitive diagnosis 3, 4.

References

Research

An uncommon cause of biliary obstruction (Mirizzi syndrome): report of five cases.

Journal of the Formosan Medical Association = Taiwan yi zhi, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.